For Alzheimer’s Patient, Hope Renewed Following Biogen Announcement
When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now,…
When biotechnology company Biogen announced the cancellation of the trial for their Alzheimer’s drug aducanumab, nearly 3,500 trial participants were left in limbo. Now,…
SAN DIEGO — I’m not a doctor. I’m not a scientist. I barely made it through my math and science classes in college. Actually,…
SAN DIEGO — The scientific data was virtually unreadable, the explanations often too complex for the layman or woman to understand. But there was…
SAN DIEGO — A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions and…
SAN DIEGO — A highly anticipated Alzheimer’s conference opened here last night with reports about a powerful new drug for treating dementia-related delusions. ACADIA…
The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Reporting on a procedure performed last year, scientists at the West Virginia University Rockefeller Neuroscience Institute said today that using low-intensity focused ultrasound is…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us